Publication | Closed Access

Brain levels of Δ1-tetrahydrocannabinol and its metabolites in mice—correlation with behaviour, and the effect of the metabolic inhibitors SKF 525A and piperonyl butoxide

Psychoactive DrugNeurophysiologyBehavioral NeuroscienceMedicineBehavioral PharmacologyCannabinoid PharmacologyBehavioural PharmacologyPsychopharmacologyBrain LevelsNeuropharmacologyNeuroscienceNeurologyMetabolic InhibitorsPharmacologyNeurochemistryCannabinoidsSocial SciencesCannabis